Cardio Diagnostics Holdings, Inc.

NASDAQ (USD): Cardio Diagnostics Holdings, Inc. (CDIO)

Last Price

0.497

Today's Change

-0.053 (9.63%)

Day's Change

0.49 - 0.55

Trading Volume

204,526

Profile
CDIO

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Meeshanthini V. Dogan Ph.D. Dr. Meeshanthini V. Dogan Ph.D.

Full Time Employees:  7 7

IPO Date:  2022-01-14 2022-01-14

CIK:  0001870144 0001870144

ISIN:  US14159C1036 US14159C1036

CUSIP:  14159C103 14159C103

Beta:  5.06 5.06

Last Dividend:  0.00 0.00

Dcf Diff:  0.50 0.50

Dcf:  -0.00 -0.00

Description

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Address

400 N Aberdeen St,
Chicago, IL 60642, US

855 226 9991

http://cardiodiagnosticsinc.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment